Synacthen 0
Sponsors
Paradigm Biopharmaceuticals (USA) Inc.
Conditions
Knee osteoarthritis pain
Phase 2
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis Pain
WithdrawnCTIS2022-500228-31-00
Target: 40Updated: 2022-06-27
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis Pain
CompletedCTIS2022-500228-31-01
Start: 2023-03-31End: 2023-11-09Target: 80Updated: 2023-03-03